Bora CDMO Bora CDMO

X

Find Lobenzarit manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

0

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Lobenzarit
Also known as: Lobenzarit disodium, 64808-48-6, Lobenzarit disodium salt, Carfenil, Lobenzarit sodium [usan], Disodium 4-chloro-2,2'-iminodibenzoate
Molecular Formula
C14H8ClNNa2O4
Molecular Weight
335.65  g/mol
InChI Key
QPJBONAWFAURGB-UHFFFAOYSA-L
FDA UNII
7Z9SP74BXF

1 2D Structure

Lobenzarit

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
disodium;2-(2-carboxylatoanilino)-4-chlorobenzoate
2.1.2 InChI
InChI=1S/C14H10ClNO4.2Na/c15-8-5-6-10(14(19)20)12(7-8)16-11-4-2-1-3-9(11)13(17)18;;/h1-7,16H,(H,17,18)(H,19,20);;/q;2*+1/p-2
2.1.3 InChI Key
QPJBONAWFAURGB-UHFFFAOYSA-L
2.1.4 Canonical SMILES
C1=CC=C(C(=C1)C(=O)[O-])NC2=C(C=CC(=C2)Cl)C(=O)[O-].[Na+].[Na+]
2.2 Other Identifiers
2.2.1 UNII
7Z9SP74BXF
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 2-((2-carboxyphenyl)amino)-4-chlorobenzoic Acid

2. 4-chloro-2,2'-iminodibenzoic Acid

3. Cca Lobenzarit

4. Disodium 4-chloro-2,2'-iminodibenzoate

5. Lobenzarit

6. Lobenzarit Disodium

7. Lobenzarit, Disodium Salt

8. Lobenzart

9. N-(2-carboxyphenyl)-4-chloroanthranilic Acid

2.3.2 Depositor-Supplied Synonyms

1. Lobenzarit Disodium

2. 64808-48-6

3. Lobenzarit Disodium Salt

4. Carfenil

5. Lobenzarit Sodium [usan]

6. Disodium 4-chloro-2,2'-iminodibenzoate

7. Sodium 2-((2-carboxylatophenyl)amino)-4-chlorobenzoate

8. 7z9sp74bxf

9. 2-((2-carboxyphenyl)amino)-4-chlorobenzoic Acid Disodium Salt

10. Benzoic Acid, 2-((2-carboxyphenyl)amino)-4-chloro-, Disodium Salt

11. Cca

12. Disodium;2-(2-carboxylatoanilino)-4-chlorobenzoate

13. Benzoic Acid, 2-[(2-carboxyphenyl)amino]-4-chloro, Disodium Salt

14. Ncgc00181760-01

15. Unii-7z9sp74bxf

16. Disodium 4-chloro-2,2'-iminobenzoate

17. Ccris 8090

18. Carfenil (tn)

19. N-(2-carboxyphenyl)-4-chloroanthranilic Acid Disodium Salt

20. Disodium Lobenzarit

21. Dsstox_cid_28532

22. Dsstox_rid_82804

23. Dsstox_gsid_48606

24. Schembl635305

25. Lobenzarit Sodium [jan]

26. Chembl2107179

27. Dtxsid8048606

28. Chebi:31778

29. Lobenzarit Sodium (jp17/usan)

30. Lobenzarit Sodium [mart.]

31. Lobenzarit Sodium [who-dd]

32. Tox21_112941

33. Mfcd00941422

34. Lobenzarit Disodium Salt [mi]

35. Akos025311428

36. Ac-26450

37. Cas-64808-48-6

38. L0278

39. D01808

40. H11986

41. A834889

42. Disodium N-(2-carboxyphenyl)-4-chloroanthranilate

43. Q27269066

44. Sodium 2-(2-carboxylatophenylamino)-4-chlorobenzoate

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 335.65 g/mol
Molecular Formula C14H8ClNNa2O4
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count5
Rotatable Bond Count2
Exact Mass334.9937240 g/mol
Monoisotopic Mass334.9937240 g/mol
Topological Polar Surface Area92.3 Ų
Heavy Atom Count22
Formal Charge0
Complexity365
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count3
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Adjuvants, Immunologic

Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)


Anti-Inflammatory Agents, Non-Steroidal

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)


Immunosuppressive Agents

Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY